Navigation Links
Saint Luke's Neuroscience Institute Announces 2013 Symposium

KANSAS CITY, Mo., July 15, 2013 /PRNewswire-USNewswire/ -- Saint Luke's Neuroscience Institute (SLNI), one of the region's pre-eminent neurological facilities, in conjunction with the University of Missouri-Kansas City (UMKC) School of Medicine and Saint Luke's Hospital of Kansas City (SLH) has opened registration for the Saint Luke's Neuroscience Institute 2013 Symposium.

The SLNI Symposium is targeted toward neurosurgeons, neurologists, neurointensivists, psychiatrists, primary care physicians, family physicians, nurses, case managers and social workers and will feature leading neurologists, neurosurgeons, and neuropsychiatrists speaking about new approaches for diagnosis and treatment of a wide array of neurological illnesses and disorders.

Program highlights include lectures on deep brain stimulation, stroke, epilepsy, Transcranial Magnetic Stimulation, brain tumor surgery, intracranial aneurysms, chronic headaches, multiple sclerosis, and facial pain.

"The topics and treatments to be discussed at the 2013 Symposium offer some of the latest, most ground-breaking advances and treatment techniques in our field," said Darren Lovick, M.D., Saint Luke's Neuroscience Institute co-surgical director. "We are incredibly excited to be able to offer this learning opportunity to physicians and nurses locally and regionally."

The symposium is scheduled for Sept. 20, 2013, and will be held at the Kansas City Public Library- Plaza Branch, 4801 Main Street, Kansas City, MO 64112, between 7:45 a.m. and 5 p.m.. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Missouri-Kansas City School of Medicine and Saint Luke's Hospital of Kansas City. The UMKC School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Missouri-Kansas City School of Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Healthcare Professionals interested in registering online for the 2013 SLNI Symposium can do so by visiting  Interested attendees can also view a complete list of the session learning objectives by visiting

About the Saint Luke's Neuroscience Institute
Saint Luke's Neuroscience Institute, a member of Saint Luke's Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of ischemic strokes. Its legacy of innovation began in 1993 when doctors performed one of the world's first intra-arterial stroke reversal procedures. Since then, Saint Luke's specialists have continued to pioneer new stroke treatments and reverse stroke's debilitating effects for thousands of patients, and is one of the world's most experienced and prolific leaders in the use of Tissue Plasminogen Activator (t-PA), a clot-busting medication for treatment of ischemic stroke. SLNI, headquartered in Kansas City, Missouri, brings together a team of the country's most accomplished neurologists to provide a comprehensive treatment center for the most complex neurological issues, such as stroke, epilepsy, brain tumors, facial pain, Parkinson's disease, Alzheimer's, headaches, aneurysms, and the latest in minimally invasive spinal surgical techniques.  SLNI's advancements in neurology have made it a national leader in neurological treatment and care.

About the University of Missouri-Kansas City School of Medicine
The UMKC School of Medicine was founded in 1971 as an innovative combined degree program. From its baccalaureate/MD curriculum to a docent system that emphasizes small group learning, the school has remained a trendsetter in medical education and research. For more information about the UMKC School of Medicine, visit You can also find us on Facebook and follow us on Twitter.

SOURCE Saint Luke's Neuroscience Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Clinovo Sponsors the First Outsourcing in Clinical Trials: Medical Devices & Diagnostics Conference, June 12-13, 2013 in Saint Paul, Minnesota
2. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
3. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
4. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
5. Data mining opens the door to predictive neuroscience
6. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
7. Intellect Neurosciences Adds Two New Tau Programs to its Alzheimers Disease Development Pipeline
8. Trinity College Dublins Neuroscience and Bioengineering Programmes Receive Postgraduate Course of the Year Awards
9. Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference
10. Biotrial, a Successful Leading CRO, Continues to Expand its Activities, Creating a Unique Neuroscience Pool of Talent and Capabilities: Biotrial Neuroscience
11. Blanchette Rockefeller Neurosciences Institute Partners with Neurotrope BioScience to Advance New Alzheimers Disease Discoveries
Post Your Comments:
(Date:11/30/2015)...  Champions Oncology, Inc. (CSBR), engaged in the development ... development and use of oncology drugs, today announced that ... presenting at the LD MICRO Investor Conference on Wednesday, ... The conference, held at the Luxe Sunset Bel Air ... will feature 200 small/micro-cap companies and is expected to ...
(Date:11/30/2015)... Ill. , Nov. 30, 2015  AbbVie, is ... program that focuses on a daily routine for managing ... take their medication can affect the way the body ... follow to their a daily routine are important. The ... to help patients better manage their hypothyroidism by establishing ...
(Date:11/28/2015)... ... 2015 , ... • Jeon Jin Bio Corp, a Korean Biotech venture company, ... , Bird Free, an oil-based, gel formula made ... including visual, smell, taste and touch, enabling safe, effective avian control without toxic chemicals ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
Breaking Biology News(10 mins):